ClinicalTrialsFinder
RecruitingNCT00552357

Risk Factors That Increase the Chance of Developing Primary Graft Dysfunction After Lung Transplantation

Clinical Risk Factors for Primary Graft Dysfunction

Sponsor

University of Pennsylvania

Enrollment

1,150 participants

Start Date

Dec 1, 2007

Study Type

OBSERVATIONAL

Conditions

Primary Graft DysfunctionLung transplantation

Summary

Primary graft dysfunction (PGD) is a severe lung complication that can occur in the days after lung transplant surgery. This study will analyze blood samples to determine if high levels of certain chemicals may increase the risk of developing PGD after a lung transplant.

Eligibility

Min Age: 13 YearsMax Age: 68 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with lung transplantation and primary graft dysfunction. The study is currently recruiting participants at 1 location. People eligible for this study include aged 13 Years to 68 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

University of Pennsylvania

Philadelphia, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00552357

Related Trials

Trifecta-Lung cfDNA-MMDx Study

NCT0583766319 locations

Prospective Reduction Of Transplant Complications Through Enhanced Preservation Therapy to Prevent Primary Graft Dysfunction

NCT072308861 location

LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.

NCT060187661 location

This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction

NCT068532231 location

Long-term Follow-up of the Offspring Born to Mothers With a Solid Organ Transplant, Transplantlines Next Generation

NCT072912581 location